Science
Cholesterol-linked drug boosts gene-targeting potency in early findings
Source: Phys.org · Published
Nucleic acid therapeutics, such as antisense oligonucleotides (ASOs), have emerged as promising platforms for treating a variety of previously hard-to-treat diseases, including neurological diseases.
Related stories
- Global satellite data reveal widening recovery gap between urban and rural vegetation
Phys.org · 12 Oct 2026, 21:20
- Measuring wildfire plumes to predict extreme fire behavior
Phys.org · 12 Oct 2026, 21:20
- Vapor-based method creates ultralight aerogels without conventional liquid-based chemistry
Phys.org · 12 Oct 2026, 21:00
- Major cities worldwide are sinking, satellite data reveal
Phys.org · 12 Oct 2026, 20:40
- High-speed microscopy captures sugar-building enzymes forming rigid pairs and flexible assemblies
Phys.org · 12 Oct 2026, 20:40
- Hurricane Simon lashes Mexico's Pacific coast, threatens landfall
Phys.org · 12 Oct 2026, 20:20
We are a news aggregator: we show the headline and a short excerpt with a link to the original source. We never republish full articles.
- #diseases
- #oligonucleotides
- #therapeutics
- #neurological
- #cholesterol
- #previously